Figure 4.
Detection of the tau protein by anti-tau conjugated IONPs with equal amounts of BSA added as a nontargeted interference in tau and BSA total concentrations of 0.2 and 20 μg/mL in (A) artificial CSF and (B) FBS-containing PBS (50 mg FBS/mL PBS), and by anti-tau conjugated Dynabeads in (C) artificial CSF and (D) FBS-containing PBS. *p < 0.05, ***p < 0.001.